Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of leukemias in man by L-asparaginase.

× No keyword cloud information.

49 in total

Review 1. Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.

Authors: J Lilleyman
Journal: Paediatr Drugs Date: 1999 Jul-Sep Impact factor: 3.022

2. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Authors: Joanne Kurtzberg; Barbara Asselin; Mark Bernstein; George R Buchanan; Brad H Pollock; Bruce M Camitta
Journal: J Pediatr Hematol Oncol Date: 2011-12 Impact factor: 1.289

Review 3. Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.

Authors: Wan Zhang; Peng Huang
Journal: Cancer Biol Ther Date: 2011-01-15 Impact factor: 4.742

4. Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.

Authors: Jean Hugues Parmentier; Maristella Maggi; Erika Tarasco; Claudia Scotti; Vassilios I Avramis; Steven D Mittelman
Journal: Leuk Res Date: 2015-04-22 Impact factor: 3.156

Review 5. Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia.

Authors: Xavier Thomas; Caroline Le Jeune
Journal: Int J Hematol Oncol Date: 2016-05-05

6. Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response.

Authors: Akito Nakamura; Tadahiro Nambu; Shunsuke Ebara; Yuka Hasegawa; Kosei Toyoshima; Yasuko Tsuchiya; Daisuke Tomita; Jun Fujimoto; Osamu Kurasawa; Chisato Takahara; Ayumi Ando; Ryuichi Nishigaki; Yoshinori Satomi; Akito Hata; Takahito Hara
Journal: Proc Natl Acad Sci U S A Date: 2018-07-30 Impact factor: 11.205

Inhibition of leukemias in man by L-asparaginase.

Review 1. Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.

2. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Review 3. Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.

4. Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.

Review 5. Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia.

6. Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response.

Review 7. From Krebs to clinic: glutamine metabolism to cancer therapy.

Review 8. Cancer chemotherapy--the first twenty-five years.

9. [Immunosuppressive effect of L-asparaginase in the graft-versus-host reaction].

10. Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine.